APO Research
Talk to an analyst

APO RESEARCH · REPORT

Neurological Biomarkers

A biomarker is a characteristic that can be objectively measured and evaluated as an indicator of a physiological as well as a pathological process or pharmacological response to a therapeutic intervention. Examples of classical biomarkers are measurable alterations in blood pressure and blood glucose in diabetes mellitus.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

A biomarker is a characteristic that can be objectively measured and evaluated as an indicator of a physiological as well as a pathological process or pharmacological response to a therapeutic intervention. Examples of classical biomarkers are measurable alterations in blood pressure and blood glucose in diabetes mellitus.

Selected research

Industry Growth & Trends

Global Neurological Biomarkers Industry Growth and Trends Forecast to 2032

21 December 2025115 pages

Choose your research edition.

Industry ResearchNeurological Biomarkers Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Neurological Biomarkers Industry Growth and Trends Forecast to 2032115 pages · $3,450 USDMarket StructureGlobal Neurological Biomarkers Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Neurological Biomarkers Market Outlook and Growth Opportunities 2026206 pages · $4,250 USDMarket Analysis & ForecastGlobal Neurological Biomarkers Market Analysis and Forecast 2026-2032208 pages · $4,950 USD

Market perspective

A biomarker is a characteristic that can be objectively measured and evaluated as an indicator of a physiological as well as a pathological process or pharmacological response to a therapeutic intervention. Examples of classical biomarkers are measurable alterations in blood pressure and blood glucose in diabetes mellitus.

Global Neurological Biomarkers key players include Thermo Fisher Scientific, Merck, Quest Diagnostics, Abbott, etc. Global top four manufacturers hold a share about 25%.

North America is the largest market, with a share over 55%, followed by Europe, and Asia-Pacific, both have a share over 35 percent.

Read the full market overview

In terms of product, Proteomics is the largest segment, with a share about 30%. And in terms of application, the largest application is Proteomics, followed by Drug Discovery, Personalized Medicine, etc.

Report Scope

This report provides a structured, data-driven view of the global Neurological Biomarkers market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Neurological Biomarkers market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Neurological Biomarkers market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Neurological Biomarkers.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Neurological Biomarkers market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Neurological Biomarkers Market by Company

Thermo Fisher Scientific

Merck

Quest Diagnostics

Abbott

Roche

Illumina

Bio-Rad Laboratories

QIAGEN

Myriad RBM

Cisbio Bioassays

Athena Diagnostics

BGI

Wuxi APP

Aepodia

Proteome Sciences

Genewiz

Neurological Biomarkers Segment by Type

Proteomics

Genomics

Imaging

Bioinformatics

Others

Neurological Biomarkers Segment by Application

Diagnostics

Drug Discovery

Personalized Medicine

Others

Neurological Biomarkers Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Neurological Biomarkers market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Neurological Biomarkers and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Neurological Biomarkers.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Neurological Biomarkers manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Neurological Biomarkers in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Proteomics Table 2. Major Company of Genomics Table 3. Major Company of Imaging Table 4. Major Company of Bioinformatics Table 5. Major Company of Others Table 6. Global Neurological Biomarkers Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Neurological Biomarkers Sales by Type (2021-2026) & (K Units) Table 8. Global Neurological Biomarkers Sales Market Share in Volume by Type (2021-2026) Table 9. Global Neurological Biomarkers Sales by Type (2021-2026) & (US$ Million) Table 10. Global Neurological Biomarkers Sales Market Share in Value by Type (2021-2026) Table 11. Global Neurological Biomarkers Price by Type (2021-2026) & (USD/Unit) Table 12. Global Neurological Biomarkers Sales by Type (2027-2032) & (K Units) Table 13. Global Neurological Biomarkers Sales Market Share in Volume by Type (2027-2032) Table 14. Global Neurological Biomarkers Sales by Type (2027-2032) & (US$ Million) Table 15. Global Neurological Biomarkers Sales Market Share in Value by Type (2027-2032) Table 16. Global Neurological Biomarkers Price by Type (2027-2032) & (USD/Unit) Table 17. North America Neurological Biomarkers Sales by Type (2021-2026) & (K Units) Table 18. North America Neurological Biomarkers Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Neurological Biomarkers Sales by Type (2021-2026) & (K Units) Table 20. Europe Neurological Biomarkers Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Neurological Biomarkers Sales by Type (2021-2026) & (K Units) Table 22. Asia-Pacific Neurological Biomarkers Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Neurological Biomarkers Sales by Type (2021-2026) & (K Units) Table 24. Latin America Neurological Biomarkers Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Neurological Biomarkers Sales by Type (2021-2026) & (K Units) Table 26. Middle East and Africa Neurological Biomarkers Sales by Type (2021-2026) & (US$ Million) Table 27. Neurological Biomarkers Industry Trends Table 28. Neurological Biomarkers Industry Drivers Table 29. Neurological Biomarkers Industry Opportunities and Challenges Table 30. Neurological Biomarkers Industry Restraints Table 31. Global Neurological Biomarkers Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Neurological Biomarkers Revenue Market Share by Company (2021-2026) Table 33. Global Neurological Biomarkers Sales by Company (2021-2026) & (K Units) Table 34. Global Neurological Biomarkers Sales Share by Company (2021-2026) Table 35. Global Neurological Biomarkers Market Price by Company (2021-2026) & (USD/Unit) Table 36. Global Neurological Biomarkers Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Neurological Biomarkers Major Company Production Sites and Headquarters Table 38. Global Neurological Biomarkers Company, Product Type & Application Table 39. Global Neurological Biomarkers Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Neurological Biomarkers by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Neurological Biomarkers Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Neurological Biomarkers Sales by Region (2021-2026) & (K Units) Table 44. Global Neurological Biomarkers Sales Market Share in Volume by Region (2021-2026) Table 45. Global Neurological Biomarkers Sales by Region (2021-2026) & (US$ Million) Table 46. Global Neurological Biomarkers Sales Market Share in Value by Region (2021-2026) Table 47. Global Neurological Biomarkers Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 48. Global Neurological Biomarkers Sales by Region (2027-2032) & (K Units) Table 49. Global Neurological Biomarkers Sales Market Share in Volume by Region (2027-2032) Table 50. Global Neurological Biomarkers Sales by Region (2027-2032) & (US$ Million) Table 51. Global Neurological Biomarkers Sales Market Share in Value by Region (2027-2032) Table 52. Global Neurological Biomarkers Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2027-2032) Table 53. Global Neurological Biomarkers Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Neurological Biomarkers Sales by Application (2021-2026) & (K Units) Table 55. Global Neurological Biomarkers Sales Market Share in Volume by Application (2021-2026) Table 56. Global Neurological Biomarkers Sales by Application (2021-2026) & (US$ Million) Table 57. Global Neurological Biomarkers Sales Market Share in Value by Application (2021-2026) Table 58. Global Neurological Biomarkers Price by Application (2021-2026) & (USD/Unit) Table 59. Global Neurological Biomarkers Sales by Application (2027-2032) & (K Units) Table 60. Global Neurological Biomarkers Sales Market Share in Volume by Application (2027-2032) Table 61. Global Neurological Biomarkers Sales by Application (2027-2032) & (US$ Million) Table 62. Global Neurological Biomarkers Sales Market Share in Value by Application (2027-2032) Table 63. Global Neurological Biomarkers Price by Application (2027-2032) & (USD/Unit) Table 64. North America Neurological Biomarkers Sales by Application (2021-2026) & (K Units) Table 65. North America Neurological Biomarkers Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Neurological Biomarkers Sales by Application (2021-2026) & (K Units) Table 67. Europe Neurological Biomarkers Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Neurological Biomarkers Sales by Application (2021-2026) & (K Units) Table 69. Asia-Pacific Neurological Biomarkers Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Neurological Biomarkers Sales by Application (2021-2026) & (K Units) Table 71. Latin America Neurological Biomarkers Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Neurological Biomarkers Sales by Application (2021-2026) & (K Units) Table 73. Middle East and Africa Neurological Biomarkers Sales by Application (2021-2026) & (US$ Million) Table 74. Thermo Fisher Scientific Company Information Table 75. Thermo Fisher Scientific Business Overview Table 76. Thermo Fisher Scientific Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 77. Thermo Fisher Scientific Neurological Biomarkers Product Portfolio Table 78. Thermo Fisher Scientific Recent Development Table 79. Merck Company Information Table 80. Merck Business Overview Table 81. Merck Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 82. Merck Neurological Biomarkers Product Portfolio Table 83. Merck Recent Development Table 84. Quest Diagnostics Company Information Table 85. Quest Diagnostics Business Overview Table 86. Quest Diagnostics Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 87. Quest Diagnostics Neurological Biomarkers Product Portfolio Table 88. Quest Diagnostics Recent Development Table 89. Abbott Company Information Table 90. Abbott Business Overview Table 91. Abbott Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 92. Abbott Neurological Biomarkers Product Portfolio Table 93. Abbott Recent Development Table 94. Roche Company Information Table 95. Roche Business Overview Table 96. Roche Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 97. Roche Neurological Biomarkers Product Portfolio Table 98. Roche Recent Development Table 99. Illumina Company Information Table 100. Illumina Business Overview Table 101. Illumina Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 102. Illumina Neurological Biomarkers Product Portfolio Table 103. Illumina Recent Development Table 104. Bio-Rad Laboratories Company Information Table 105. Bio-Rad Laboratories Business Overview Table 106. Bio-Rad Laboratories Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 107. Bio-Rad Laboratories Neurological Biomarkers Product Portfolio Table 108. Bio-Rad Laboratories Recent Development Table 109. QIAGEN Company Information Table 110. QIAGEN Business Overview Table 111. QIAGEN Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 112. QIAGEN Neurological Biomarkers Product Portfolio Table 113. QIAGEN Recent Development Table 114. Myriad RBM Company Information Table 115. Myriad RBM Business Overview Table 116. Myriad RBM Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 117. Myriad RBM Neurological Biomarkers Product Portfolio Table 118. Myriad RBM Recent Development Table 119. Cisbio Bioassays Company Information Table 120. Cisbio Bioassays Business Overview Table 121. Cisbio Bioassays Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 122. Cisbio Bioassays Neurological Biomarkers Product Portfolio Table 123. Cisbio Bioassays Recent Development Table 124. Athena Diagnostics Company Information Table 125. Athena Diagnostics Business Overview Table 126. Athena Diagnostics Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 127. Athena Diagnostics Neurological Biomarkers Product Portfolio Table 128. Athena Diagnostics Recent Development Table 129. BGI Company Information Table 130. BGI Business Overview Table 131. BGI Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 132. BGI Neurological Biomarkers Product Portfolio Table 133. BGI Recent Development Table 134. Wuxi APP Company Information Table 135. Wuxi APP Business Overview Table 136. Wuxi APP Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 137. Wuxi APP Neurological Biomarkers Product Portfolio Table 138. Wuxi APP Recent Development Table 139. Aepodia Company Information Table 140. Aepodia Business Overview Table 141. Aepodia Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 142. Aepodia Neurological Biomarkers Product Portfolio Table 143. Aepodia Recent Development Table 144. Proteome Sciences Company Information Table 145. Proteome Sciences Business Overview Table 146. Proteome Sciences Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 147. Proteome Sciences Neurological Biomarkers Product Portfolio Table 148. Proteome Sciences Recent Development Table 149. Genewiz Company Information Table 150. Genewiz Business Overview Table 151. Genewiz Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 152. Genewiz Neurological Biomarkers Product Portfolio Table 153. Genewiz Recent Development Table 154. North America Neurological Biomarkers Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 155. North America Neurological Biomarkers Sales by Country (2021-2026) & (K Units) Table 156. North America Neurological Biomarkers Sales Market Share by Country (2021-2026) Table 157. North America Neurological Biomarkers Sales Forecast by Country (2027-2032) & (K Units) Table 158. North America Neurological Biomarkers Sales Market Share Forecast by Country (2027-2032) Table 159. North America Neurological Biomarkers Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 160. North America Neurological Biomarkers Market Size by Country (2021-2026) & (US$ Million) Table 161. North America Neurological Biomarkers Market Share by Country (2021-2026) Table 162. North America Neurological Biomarkers Market Size Forecast by Country (2027-2032) & (US$ Million) Table 163. North America Neurological Biomarkers Market Share Forecast by Country (2027-2032) Table 164. Europe Neurological Biomarkers Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 165. Europe Neurological Biomarkers Sales by Country (2021-2026) & (K Units) Table 166. Europe Neurological Biomarkers Sales Market Share by Country (2021-2026) Table 167. Europe Neurological Biomarkers Sales Forecast by Country (2027-2032) & (K Units) Table 168. Europe Neurological Biomarkers Sales Market Share Forecast by Country (2027-2032) Table 169. Europe Neurological Biomarkers Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 170. Europe Neurological Biomarkers Market Size by Country (2021-2026) & (US$ Million) Table 171. Europe Neurological Biomarkers Market Share by Country (2021-2026) Table 172. Europe Neurological Biomarkers Market Size Forecast by Country (2027-2032) & (US$ Million) Table 173. Europe Neurological Biomarkers Market Share Forecast by Country (2027-2032) Table 174. Asia-Pacific Neurological Biomarkers Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 175. Asia-Pacific Neurological Biomarkers Sales by Country (2021-2026) & (K Units) Table 176. Asia-Pacific Neurological Biomarkers Sales Market Share by Country (2021-2026) Table 177. Asia-Pacific Neurological Biomarkers Sales Forecast by Country (2027-2032) & (K Units) Table 178. Asia-Pacific Neurological Biomarkers Sales Market Share Forecast by Country (2027-2032) Table 179. Asia-Pacific Neurological Biomarkers Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 180. Asia-Pacific Neurological Biomarkers Market Size by Country (2021-2026) & (US$ Million) Table 181. Asia-Pacific Neurological Biomarkers Market Share by Country (2021-2026) Table 182. Asia-Pacific Neurological Biomarkers Market Size Forecast by Country (2027-2032) & (US$ Million) Table 183. Asia-Pacific Neurological Biomarkers Market Share Forecast by Country (2027-2032) Table 184. Latin America Neurological Biomarkers Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 185. Latin America Neurological Biomarkers Sales by Country (2021-2026) & (K Units) Table 186. Latin America Neurological Biomarkers Sales Market Share by Country (2021-2026) Table 187. Latin America Neurological Biomarkers Sales Forecast by Country (2027-2032) & (K Units) Table 188. Latin America Neurological Biomarkers Sales Market Share Forecast by Country (2027-2032) Table 189. Latin America Neurological Biomarkers Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 190. Latin America Neurological Biomarkers Market Size by Country (2021-2026) & (US$ Million) Table 191. Latin America Neurological Biomarkers Market Share by Country (2021-2026) Table 192. Latin America Neurological Biomarkers Market Size Forecast by Country (2027-2032) & (US$ Million) Table 193. Latin America Neurological Biomarkers Market Share Forecast by Country (2027-2032) Table 194. Middle East and Africa Neurological Biomarkers Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 195. Middle East and Africa Neurological Biomarkers Sales by Country (2021-2026) & (K Units) Table 196. Middle East and Africa Neurological Biomarkers Sales Market Share by Country (2021-2026) Table 197. Middle East and Africa Neurological Biomarkers Sales Forecast by Country (2027-2032) & (K Units) Table 198. Middle East and Africa Neurological Biomarkers Sales Market Share Forecast by Country (2027-2032) Table 199. Middle East and Africa Neurological Biomarkers Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 200. Middle East and Africa Neurological Biomarkers Market Size by Country (2021-2026) & (US$ Million) Table 201. Middle East and Africa Neurological Biomarkers Market Share by Country (2021-2026) Table 202. Middle East and Africa Neurological Biomarkers Market Size Forecast by Country (2027-2032) & (US$ Million) Table 203. Middle East and Africa Neurological Biomarkers Market Share Forecast by Country (2027-2032) Table 204. Key Raw Materials Table 205. Raw Materials Key Suppliers Table 206. Neurological Biomarkers Distributors List Table 207. Neurological Biomarkers Customers List Table 208. Research Programs/Design for This Report Table 209. Authors List of This Report Table 210. Secondary Sources Table 211. Primary Sources List of Figures Figure 1. Neurological Biomarkers Image Figure 2. Global Neurological Biomarkers Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Neurological Biomarkers Market Size (2021-2032) & (US$ Million) Figure 4. Global Neurological Biomarkers Sales (2021-2032) & (K Units) Figure 5. Proteomics Image Figure 6. Global Proteomics Sales YoY Growth (2021-2032) & (K Units) Figure 7. Genomics Image Figure 8. Global Genomics Sales YoY Growth (2021-2032) & (K Units) Figure 9. Imaging Image Figure 10. Global Imaging Sales YoY Growth (2021-2032) & (K Units) Figure 11. Bioinformatics Image Figure 12. Global Bioinformatics Sales YoY Growth (2021-2032) & (K Units) Figure 13. Others Image Figure 14. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 15. Global Neurological Biomarkers Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Neurological Biomarkers Market Share by Type 2025 VS 2032 Figure 17. North America Neurological Biomarkers Sales Market Share in Volume by Type in 2025 Figure 18. North America Neurological Biomarkers Sales Market Share in Value by Type in 2025 Figure 19. Europe Neurological Biomarkers Sales Market Share in Volume by Type in 2025 Figure 20. Europe Neurological Biomarkers Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Neurological Biomarkers Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Neurological Biomarkers Sales Market Share in Value by Type in 2025 Figure 23. Latin America Neurological Biomarkers Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Neurological Biomarkers Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Neurological Biomarkers Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Neurological Biomarkers Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Neurological Biomarkers Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Diagnostics Image Figure 30. Global Diagnostics Sales YoY Growth (2021-2032) & (K Units) Figure 31. Drug Discovery Image Figure 32. Global Drug Discovery Sales YoY Growth (2021-2032) & (K Units) Figure 33. Personalized Medicine Image Figure 34. Global Personalized Medicine Sales YoY Growth (2021-2032) & (K Units) Figure 35. Others Image Figure 36. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 37. Global Neurological Biomarkers Market Size Overview by Application (2021-2032) & (US$ Million) Figure 38. Global Neurological Biomarkers Market Share by Application 2025 VS 2032 Figure 39. North America Neurological Biomarkers Sales Market Share in Volume by Application in 2025 Figure 40. North America Neurological Biomarkers Sales Market Share in Value by Application in 2025 Figure 41. Europe Neurological Biomarkers Sales Market Share in Volume by Application in 2025 Figure 42. Europe Neurological Biomarkers Sales Market Share in Value by Application in 2025 Figure 43. Asia-Pacific Neurological Biomarkers Sales Market Share in Volume by Application in 2025 Figure 44. Asia-Pacific Neurological Biomarkers Sales Market Share in Value by Application in 2025 Figure 45. Latin America Neurological Biomarkers Sales Market Share in Volume by Application in 2025 Figure 46. Latin America Neurological Biomarkers Sales Market Share in Value by Application in 2025 Figure 47. Middle East and Africa Neurological Biomarkers Sales Market Share in Volume by Application in 2025 Figure 48. Middle East and Africa Neurological Biomarkers Sales Market Share in Value by Application in 2025 Figure 49. North America Neurological Biomarkers Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. North America Neurological Biomarkers Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. North America Neurological Biomarkers Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. North America Neurological Biomarkers Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Neurological Biomarkers Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Europe Neurological Biomarkers Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Neurological Biomarkers Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Europe Neurological Biomarkers Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Neurological Biomarkers Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Asia-Pacific Neurological Biomarkers Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific Neurological Biomarkers Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Asia-Pacific Neurological Biomarkers Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Neurological Biomarkers Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 62. Latin America Neurological Biomarkers Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America Neurological Biomarkers Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Latin America Neurological Biomarkers Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Neurological Biomarkers Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 66. Middle East and Africa Neurological Biomarkers Sales Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa Neurological Biomarkers Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 68. Middle East and Africa Neurological Biomarkers Market Share by Country: 2021 VS 2025 VS 2032 Figure 69. Neurological Biomarkers Value Chain Figure 70. Key Raw Materials Price Figure 71. Manufacturing Cost Structure Figure 72. Neurological Biomarkers Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Proteomics
  • Genomics
  • Imaging
  • Bioinformatics
  • Others
Applications
  • Diagnostics
  • Drug Discovery
  • Personalized Medicine
  • Others
Companies covered
  • Thermo Fisher Scientific
  • Merck
  • Quest Diagnostics
  • Abbott
  • Roche
  • Illumina
  • Bio-Rad Laboratories
  • QIAGEN
  • Myriad RBM
  • Cisbio Bioassays
  • Athena Diagnostics
  • BGI
  • Wuxi APP
  • Aepodia
  • Proteome Sciences
  • Genewiz

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Neurological Biomarkers Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Neurological Biomarkers Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Neurological Biomarkers Market by Type
  6. 1.3.1 Proteomics
  7. 1.3.2 Genomics
  8. 1.3.3 Imaging
  9. 1.3.4 Bioinformatics
  10. 1.3.5 Others
  11. 1.4 Global Neurological Biomarkers Market Size by Type
  12. 1.4.1 Global Neurological Biomarkers Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Neurological Biomarkers Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Neurological Biomarkers Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Neurological Biomarkers Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Neurological Biomarkers Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Neurological Biomarkers Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Neurological Biomarkers Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Neurological Biomarkers Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Neurological Biomarkers Industry Trends
  2. 2.2 Neurological Biomarkers Industry Drivers
  3. 2.3 Neurological Biomarkers Industry Opportunities and Challenges
  4. 2.4 Neurological Biomarkers Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Neurological Biomarkers Revenue (2021-2026)
  2. 3.2 Global Top Players by Neurological Biomarkers Sales (2021-2026)
  3. 3.3 Global Top Players by Neurological Biomarkers Price (2021-2026)
  4. 3.4 Global Neurological Biomarkers Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Neurological Biomarkers Major Company Production Sites & Headquarters
  6. 3.6 Global Neurological Biomarkers Company, Product Type & Application
  7. 3.7 Global Neurological Biomarkers Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Neurological Biomarkers Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Neurological Biomarkers Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Neurological Biomarkers Tier 1, Tier 2, and Tier 3
4 Neurological Biomarkers Regional Status and Outlook
  1. 4.1 Global Neurological Biomarkers Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Neurological Biomarkers Historic Market Size by Region
  3. 4.2.1 Global Neurological Biomarkers Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Neurological Biomarkers Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Neurological Biomarkers Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Neurological Biomarkers Forecasted Market Size by Region
  7. 4.3.1 Global Neurological Biomarkers Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Neurological Biomarkers Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Neurological Biomarkers Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Neurological Biomarkers by Application
  1. 5.1 Neurological Biomarkers Market by Application
  2. 5.1.1 Diagnostics
  3. 5.1.2 Drug Discovery
  4. 5.1.3 Personalized Medicine
  5. 5.1.4 Others
  6. 5.2 Global Neurological Biomarkers Market Size by Application
  7. 5.2.1 Global Neurological Biomarkers Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Neurological Biomarkers Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Neurological Biomarkers Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Neurological Biomarkers Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Neurological Biomarkers Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Neurological Biomarkers Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Neurological Biomarkers Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Neurological Biomarkers Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Thermo Fisher Scientific
  2. 6.1.1 Thermo Fisher Scientific Company Information
  3. 6.1.2 Thermo Fisher Scientific Business Overview
  4. 6.1.3 Thermo Fisher Scientific Neurological Biomarkers Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Thermo Fisher Scientific Neurological Biomarkers Product Portfolio
  6. 6.1.5 Thermo Fisher Scientific Recent Developments
  7. 6.2 Merck
  8. 6.2.1 Merck Company Information
  9. 6.2.2 Merck Business Overview
  10. 6.2.3 Merck Neurological Biomarkers Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Merck Neurological Biomarkers Product Portfolio
  12. 6.2.5 Merck Recent Developments
  13. 6.3 Quest Diagnostics
  14. 6.3.1 Quest Diagnostics Company Information
  15. 6.3.2 Quest Diagnostics Business Overview
  16. 6.3.3 Quest Diagnostics Neurological Biomarkers Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Quest Diagnostics Neurological Biomarkers Product Portfolio
  18. 6.3.5 Quest Diagnostics Recent Developments
  19. 6.4 Abbott
  20. 6.4.1 Abbott Company Information
  21. 6.4.2 Abbott Business Overview
  22. 6.4.3 Abbott Neurological Biomarkers Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Abbott Neurological Biomarkers Product Portfolio
  24. 6.4.5 Abbott Recent Developments
  25. 6.5 Roche
  26. 6.5.1 Roche Company Information
  27. 6.5.2 Roche Business Overview
  28. 6.5.3 Roche Neurological Biomarkers Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Roche Neurological Biomarkers Product Portfolio
  30. 6.5.5 Roche Recent Developments
  31. 6.6 Illumina
  32. 6.6.1 Illumina Company Information
  33. 6.6.2 Illumina Business Overview
  34. 6.6.3 Illumina Neurological Biomarkers Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Illumina Neurological Biomarkers Product Portfolio
  36. 6.6.5 Illumina Recent Developments
  37. 6.7 Bio-Rad Laboratories
  38. 6.7.1 Bio-Rad Laboratories Company Information
  39. 6.7.2 Bio-Rad Laboratories Business Overview
  40. 6.7.3 Bio-Rad Laboratories Neurological Biomarkers Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Bio-Rad Laboratories Neurological Biomarkers Product Portfolio
  42. 6.7.5 Bio-Rad Laboratories Recent Developments
  43. 6.8 QIAGEN
  44. 6.8.1 QIAGEN Company Information
  45. 6.8.2 QIAGEN Business Overview
  46. 6.8.3 QIAGEN Neurological Biomarkers Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 QIAGEN Neurological Biomarkers Product Portfolio
  48. 6.8.5 QIAGEN Recent Developments
  49. 6.9 Myriad RBM
  50. 6.9.1 Myriad RBM Company Information
  51. 6.9.2 Myriad RBM Business Overview
  52. 6.9.3 Myriad RBM Neurological Biomarkers Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Myriad RBM Neurological Biomarkers Product Portfolio
  54. 6.9.5 Myriad RBM Recent Developments
  55. 6.10 Cisbio Bioassays
  56. 6.10.1 Cisbio Bioassays Company Information
  57. 6.10.2 Cisbio Bioassays Business Overview
  58. 6.10.3 Cisbio Bioassays Neurological Biomarkers Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Cisbio Bioassays Neurological Biomarkers Product Portfolio
  60. 6.10.5 Cisbio Bioassays Recent Developments
  61. 6.11 Athena Diagnostics
  62. 6.11.1 Athena Diagnostics Company Information
  63. 6.11.2 Athena Diagnostics Business Overview
  64. 6.11.3 Athena Diagnostics Neurological Biomarkers Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Athena Diagnostics Neurological Biomarkers Product Portfolio
  66. 6.11.5 Athena Diagnostics Recent Developments
  67. 6.12 BGI
  68. 6.12.1 BGI Company Information
  69. 6.12.2 BGI Business Overview
  70. 6.12.3 BGI Neurological Biomarkers Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 BGI Neurological Biomarkers Product Portfolio
  72. 6.12.5 BGI Recent Developments
  73. 6.13 Wuxi APP
  74. 6.13.1 Wuxi APP Company Information
  75. 6.13.2 Wuxi APP Business Overview
  76. 6.13.3 Wuxi APP Neurological Biomarkers Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Wuxi APP Neurological Biomarkers Product Portfolio
  78. 6.13.5 Wuxi APP Recent Developments
  79. 6.14 Aepodia
  80. 6.14.1 Aepodia Company Information
  81. 6.14.2 Aepodia Business Overview
  82. 6.14.3 Aepodia Neurological Biomarkers Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Aepodia Neurological Biomarkers Product Portfolio
  84. 6.14.5 Aepodia Recent Developments
  85. 6.15 Proteome Sciences
  86. 6.15.1 Proteome Sciences Company Information
  87. 6.15.2 Proteome Sciences Business Overview
  88. 6.15.3 Proteome Sciences Neurological Biomarkers Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Proteome Sciences Neurological Biomarkers Product Portfolio
  90. 6.15.5 Proteome Sciences Recent Developments
  91. 6.16 Genewiz
  92. 6.16.1 Genewiz Company Information
  93. 6.16.2 Genewiz Business Overview
  94. 6.16.3 Genewiz Neurological Biomarkers Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Genewiz Neurological Biomarkers Product Portfolio
  96. 6.16.5 Genewiz Recent Developments
7 North America by Country
  1. 7.1 North America Neurological Biomarkers Sales by Country
  2. 7.1.1 North America Neurological Biomarkers Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Neurological Biomarkers Sales by Country (2021-2026)
  4. 7.1.3 North America Neurological Biomarkers Sales Forecast by Country (2027-2032)
  5. 7.2 North America Neurological Biomarkers Market Size by Country
  6. 7.2.1 North America Neurological Biomarkers Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Neurological Biomarkers Market Size by Country (2021-2026)
  8. 7.2.3 North America Neurological Biomarkers Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Neurological Biomarkers Sales by Country
  2. 8.1.1 Europe Neurological Biomarkers Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Neurological Biomarkers Sales by Country (2021-2026)
  4. 8.1.3 Europe Neurological Biomarkers Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Neurological Biomarkers Market Size by Country
  6. 8.2.1 Europe Neurological Biomarkers Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Neurological Biomarkers Market Size by Country (2021-2026)
  8. 8.2.3 Europe Neurological Biomarkers Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Neurological Biomarkers Sales by Country
  2. 9.1.1 Asia-Pacific Neurological Biomarkers Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Neurological Biomarkers Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Neurological Biomarkers Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Neurological Biomarkers Market Size by Country
  6. 9.2.1 Asia-Pacific Neurological Biomarkers Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Neurological Biomarkers Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Neurological Biomarkers Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Neurological Biomarkers Sales by Country
  2. 10.1.1 South America Neurological Biomarkers Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Neurological Biomarkers Sales by Country (2021-2026)
  4. 10.1.3 South America Neurological Biomarkers Sales Forecast by Country (2027-2032)
  5. 10.2 South America Neurological Biomarkers Market Size by Country
  6. 10.2.1 South America Neurological Biomarkers Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Neurological Biomarkers Market Size by Country (2021-2026)
  8. 10.2.3 South America Neurological Biomarkers Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Neurological Biomarkers Sales by Country
  2. 11.1.1 Middle East and Africa Neurological Biomarkers Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Neurological Biomarkers Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Neurological Biomarkers Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Neurological Biomarkers Market Size by Country
  6. 11.2.1 Middle East and Africa Neurological Biomarkers Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Neurological Biomarkers Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Neurological Biomarkers Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Neurological Biomarkers Value Chain Analysis
  2. 12.1.1 Neurological Biomarkers Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Neurological Biomarkers Production Mode & Process
  7. 12.2 Neurological Biomarkers Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Neurological Biomarkers Distributors
  10. 12.2.3 Neurological Biomarkers Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst